Atopic dermatitis increases the risk of infective endocarditis in prosthetic heart valve patients – A retrospective study
Department of Medicine at Staten Island University Hospital/Northwell Health, Staten Island, New York
Department of Dermatology, Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York
Article notes
Untitled section
Collection date 2025 Feb.
Untitled section
Key words: asthma, atopic dermatitis, bacteremia, cannabinoid use, eczema, infective endocarditis, prosthetic heart valve, skin infection
To the Editor: Practicing adequate skin hygiene is an important part of infective endocarditis (IE) prophylaxis in prosthetic heart valve patients.1 Prosthetic valve patients are at increased risk for contracting IE because of increased bacterial adherence to prosthetic device material. The study of skin conditions like atopic dermatitis (AD) with altered skin microbiota, increased skin inflammation and disrupted skin barrier in this context might identify additional important risk factors that can further increase the IE risk in prosthetic valve patients. We retrospectively evaluated the association of AD with IE in prosthetic valve patients.
Prosthetic valve patients from the National Inpatient Sample Database 2016-2018 were selected. Patients with intravenous drug use, infected central lines, past history of IE, less than 18 years old, and with missing data (age, gender, and race) were excluded.2 This cohort was subsequently stratified by AD. Patient demographics and comorbidities were collected (Table I). The primary outcome was IE. Univariate analyses were conducted using chi-square and student’s t-tests. Multivariate analysis was conducted using binary logistic regression.
| Variables | Atopic dermatitis N = 353 N (%) | Nonatopic dermatitis N = 188262 N (%) | P value |
|---|---|---|---|
| Age (y ± SD) | 72.17 ± 4.26 | 72.55 ± 13.86 | .605 |
| Female | 123 (34.8) | 84598 (44.9) | <.001 |
| Race | .724 | ||
| White | 150162 (79.8) | 287 (81.3) | |
| Black | 17371 (9.2) | 32 (9.1) | |
| Other | 20729 (11.0) | 34 (10.6) | |
| Smoking | 122 (34.6) | 62146 (33.0) | .574 |
| Cancer | 23 (6.5) | 14482 (7.7) | .466 |
| Prior PPM | 49 (13.9) | 31099 (16.5) | .207 |
| Prior ICD | 23 (6.5) | 13751 (7.3) | .641 |
| Dental disease | 0 (0.0) | 139 (0.1) | >.999 |
| AIDS | 2 (0.6) | 687 (0.4) | .853 |
| Coronary artery disease | 190 (53.8) | 102603 (54.5) | .841 |
| COPD | 110 (31.2) | 49188 (26.1) | .037 |
| Diabetes mellitus | 117 (33.1) | 65836 (35.0) | .507 |
| Dyslipidemia | 144 (40.8) | 74298 (39.5) | .649 |
| Hypertension | 99 (28.0) | 62561 (33.2) | .044 |
| Peripheral vascular disease | 6 (1.7) | 4503 (2.4) | .499 |
| Anemia | 111 (31.4) | 52358 (27.8) | .144 |
| Smoking | 122 (34.6) | 62146 (33.0) | .574 |
| Atrial fibrillation | 139 (39.4) | 66478 (35.3) | .123 |
| Chronic liver disease | 22 (6.2) | 11219 (6.0) | .917 |
| Carotid artery disease | 13 (3.7) | 4713 (2.5) | .213 |
| Chronic kidney disease | 132 (37.4) | 63716 (33.8) | .176 |
| Coagulable disorders | 53 (15.0) | 23138 (12.3) | .140 |
| Chronic heart failure | 168 (47.6) | 84372 (44.8) | .320 |
| Pulmonary hypertension | 49 (13.9) | 24393 (13.0) | .662 |
| Prior TIA/CVA | 48 (13.6) | 27879 (14.8) | .572 |
| Obesity | 63 (17.8) | 26848 (14.3) | .065 |
| Infective endocarditis | 12 (3.4) | 3278 (1.7) | .017 |
Of 188,615 patients, 353 patients had AD and 188,262 patients did not. AD cohort had more males and less rates of hypertension (Table I). AD patients had increased IE rates compared to non-AD patients (1.7%; Table I). After logistic regression analysis, AD had increased risk for IE (adjusted OR: 2.0 [1.1-3.5]; P = .023; Table II).
| Variables | Odds ratio | 95% confidence interval | P value |
|---|---|---|---|
| Multivariate logistic regression | |||
| Atopic dermatitis (adjusted) | 2.0 | 1.1-3.5 | .023 |
Studies have reported possible links between AD and IE, usually in the setting of active skin infection.3,4 In a retrospective cohort study on 120 patients, 6.7% of IE patients had AD.3 Chronic skin diseases, like AD, have been suggested to increase the risk for IE and bacteremia.1 This might be due to a change in the skin microbiota and increased skin inflammation with disrupted skin barrier in patients with AD. In most of these cases, the most common pathogen was Staphylococcus aureus, which is also the most common for prosthetic valve IE.5 The weakened skin barrier can lead to increased bacterial and fungal entry, hence leading to increased susceptibility to fungemia and bacteremia. Thus, optimized treatment of AD with strict cutaneous hygiene, including advice on tattoos and skin piercings, are likely to be important for IE prevention in prosthetic valve patients.1
The main limitations of our study are that it is retrospective in nature and uses administrative billing data with International Classification of Diseases, Tenth Revision codes which are prone to error. The main strengths of our study include assessing data from many patients with prosthetic valves at a national level.
In conclusion, AD was independently associated with increased IE in patients with prosthetic valves. Although IE incidence was small, patients with prosthetic heart valves should be advised that it is important to properly optimize the treatment and management of their AD.
Conflicts of interest
None disclosed.
Footnotes
Footnote Group
References
Untitled section
References
- 1.Delgado V., Ajmone Marsan N., de Waha S., et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023;44(39):3948–4042. doi: 10.1093/eurheartj/ehad193.
- 2.Makhoul G.W., Mustafa A., Wei C., et al. Heart failure - an unexplored risk factor for infective endocarditis after pacemaker implantation. J Cardiol. 2024;84:161–164. doi: 10.1016/j.jjcc.2024.04.002.
- 3.Fukunaga N., Okada Y., Konishi Y., Murashita T., Koyama T. Pay attention to valvular disease in the presence of atopic dermatitis. Circ J. 2013;77(7):1862–1866. doi: 10.1253/circj.cj-12-1371.
- 4.Hibi A., Ito C. Infective endocarditis due to methicillin-sensitive Staphylococcus aureus in a patient with untreated atopic dermatitis who was successfully treated without surgery. Oxf Med Case Rep. 2018;2018(3):115–118. doi: 10.1093/omcr/omx113.
- 5.Kouijzer J.J.P., Noordermeer D.J., van Leeuwen W.J., Verkaik N.J., Lattwein K.R. Native valve, prosthetic valve, and cardiac device-related infective endocarditis: a review and update on current innovative diagnostic and therapeutic strategies. Front Cell Dev Biol. 2022;10 doi: 10.3389/fcell.2022.995508.